standard technique along with others involving higher concentrations. I believe that choice to have been both ethically acceptable and scientifically appropriate. May I, perhaps, quote from our previous report (Crawford et al., 1976): "As only two (0.6%) of the patients in the combined 0.2% series recollected discomfort during the operation, we are reluctant to advise an increase in the depth of anaesthesia to reduce the incidence of these complications." We have now formally investigated the problem and as a result have assuaged our reluctance.
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Following surgery, heart transplant recipients are at risk from complications associated with heavy immunosuppressive regimens, for example chronic infections, aseptic necrosis of the hip, the development of neoplasms and, in particular, lymphomas. Patients will usually be treated for these complications at their local hospitals rather than being referred back to the transplant centre. As the number of long-term survivors continues to grow it is to be expected that increasing numbers of anaesthetists will be asked to deal with them.
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